Skip to Main Content

Paper Details

Late relapse after CAR-T cell therapy for adult patients with hematologic malignancies: A definite evidence from systematic review and meta-analysis on individual data.
1
2023
-T cell, Acute Lymphoblastic Leukemia, B-cell malignancies, CAR, CAR-T, CAR-T cell, CAR-T cell therapy, Chimeric Antigen Receptor, Chimeric Antigen Receptor (CAR)-modified T lymphocytes, Follicular Lymphoma, Large B-Cell Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, axicabtagene, blood malignancies, brexucabtagene, ciltacabtagene, hematologic malignancies, idecabtagene, lisocabtagene, malignancy, patients
Author NameAffiliation
Giuseppe PaolissoUniversity of Campania "Luigi Vanvitelli"
  • 1 - 1

Datasets

Release 1.2